CAS registry number (Chemical Abstracts Service)
Treatment of neonatal respiratory distress syndrome
An extract of porcine lung containing not less than 90% of phospholipids, about 1% of hydrophobic proteins (SP-B and SP-C) and about 9% of other lipids (BAN)
- Surfactant (Schwein) (German)
- Poractant Alfa (OS: BAN)
- PLS (IS)
- Porcine lung surfactant extract (IS)
- UNII-KE2U2023NP (IS)
Central Procurement & Supplies Unit, Malta; Chiesi, Bosnia & Herzegowina; Chiesi, Taiwan; Providens, Croatia (Hrvatska); Varnavas, Cyprus; Chiesi, Belgium; Chiesi, China; Chiesi, Czech Republic; Chiesi, Malta; Chiesi, Slovakia; Chiesi Pharmaceuticals, Poland; Nycomed, Argentina
- Curosurf (pediatric)
2care4, Norway; Angelini, Portugal; Ascent, Australia; Chiesi, Germany; Chiesi, Estonia; Chiesi, Spain; Chiesi, France; Chiesi, United Kingdom; Chiesi, Greece; Chiesi, Hong Kong; Chiesi, Ireland; Chiesi, Netherlands; Chiesi, Serbia; Chiesi, Thailand; Chiesi, Turkey; Chiesi Farmaceutici, Georgia; Chiesi Farmaceutici, Israel; Chiesi Farmaceutici, Italy; Chiesi Pharmaceuticals, Austria; Chiesi Pharmaceuticals, Poland; Cornerstone, United States; Douglas, New Zealand; Farmalab, Brazil; Norameda, Lithuania; Orifarm, Norway; Safeline, South Africa; Takeda, Norway; Takeda Pharma, Switzerland; Takeda Pharma, Denmark; Takeda Pharma, Sweden; Torrex, Slovenia; Torrex Chiesi, Bulgaria
|BAN||British Approved Name|
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.